Calcium citrate
Calcium citrate has been studied in 4 papers since 2007: 3 trials in people, 1 in animals. The newest paper, Feb 12, 2024: “Evaluating adherence, tolerability and safety of oral calcium citrate in elderly osteopenic subjects: a real-life non-interventional, prospective, multicenter study”.
See all 12 papers on calcium citrate
At a glance
The findings reach people, from one lab or study. 2 independent labs in 2 countries; 3 trials, none about aging.
“Both systolic and diastolic blood pressure decreased from baseline to follow-up visit (change of -2.8 ± 13.9 mmHg, p = 0.0102 and -2.1 ± 10.4 mmHg, p = 0.0116, respectively).”
None of its findings points the other way.
- 2 independent labs in 2 countries
- 3 trials, none about aging
- Funders: Auckland Medical Research Foundation and 8 more
- 2 of 4 findings with company ties
- Human trial3
- Animals1
Studies in people
2 studies gave calcium citrate to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
down: Decreases diastolic blood pressure79.5 ± 8.7 mmHg to 77.4 ± 8.6 mmHg | Trialwithin 12 months | 268 people245 females (91.4%) and 23 males (8.6%)70.0 ± 4.5 yearsOlder adults; Patient cohorts | Aging clinical and experimental research, Feb 12, 2024 |
no change: Has no effect on diastolic blood pressure up: Increases serum calcium | Randomized trial6 hours | 40 peopleWomenmean age 71 yearsOlder adults; Postmenopausal women; Healthy postmenopausal women | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, Aug 20, 2016 |
What did studies of calcium citrate find?
3Studies of calcium citrate measured 3 outcomes: diastolic blood pressure, serum calcium and diastolic blood pressure.
Diastolic blood pressure
downin humans1
1 study
Diastolic blood pressure
downin humans1
Calcium citrate decreases diastolic blood pressure in humans (79.5 ± 8.7 mmHg to 77.4 ± 8.6 mmHg).
“Likewise, DBP was also seen to decrease from 79.5 ± 8.7 mmHg to 77.4 ± 8.6 mmHg (baseline to V2) (p = 0.0116).”
Human trialwithin 12 months
Aging clinical and experimental research
Calcium citrate decreases diastolic blood pressure in humans (osteopenia) (-2.1 ± 10.4 mmHg, p = 0.0116).
“Both systolic and diastolic blood pressure decreased from baseline to follow-up visit (change of -2.8 ± 13.9 mmHg, p = 0.0102 and -2.1 ± 10.4 mmHg, p = 0.0116, respectively).”
Human trialosteopenia500 mg dailyup to one yearn = 268
Aging clinical and experimental research
Serum calcium
upin humans1
1 study
Serum calcium
upin humans1
Calcium citrate increases serum calcium in humans (Healthy postmenopausal women; compared with placebo).
“Ionised and total calcium concentrations increased after calcium (p < 0.0001 versus placebo).”
Human trialHealthy postmenopausal women; compared with placebocitrateserum1 g of calcium6 hoursfemalesn = 40
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Diastolic blood pressure
no changein humans1
1 study
Diastolic blood pressure
no changein humans1
Calcium citrate showed no clear effect on diastolic blood pressure in humans (Healthy postmenopausal women; compared with placebo).
“The reduction in diastolic blood pressure was similar after calcium and placebo.”
Human trialHealthy postmenopausal women; compared with placebocitrate1 g of calcium6 hoursfemalesn = 40
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Trial sponsors
Company1 trialPhase 3214 people
Children's Hospital Los Angeles
1 trialPhase 276 people
Children's Hospital Medical Center, Cincinnati
1 trialPhase 276 people
1 trial273 people